Coronavirus vaccine: A second dry run will be held in all the states for COVID-19 vaccination
New Delhi:
A second dry run for COVID-19 vaccination will be held in all the states on Friday, sources have said. The first massive dry run was held on January 2. The exercise checked the best way to vaccinate people against COVID-19 and plug loopholes in logistics and training.
The day-long drive on Friday will again test the operational feasibility of CoWIN application in a field environment. Short for Covid Vaccine Intelligence Network, CoWIN is a digital platform to roll out and scale up the vaccination drive.
India s approval of homegrown vaccine criticised over lack of data | Kat Country 98 9 katcountry989.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from katcountry989.com Daily Mail and Mail on Sunday newspapers.
Coronavirus Cases in India: The recovery rate is 96.16 per cent.
New Delhi:
India s drugs regulator on Sunday approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country, paving the way for a massive inoculation drive.
The approval by the Drugs Controller General of India (DCGI) was given on the basis of recommendations submitted by a COVID-19 subject expert committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO). After adequate examination, CDSCO has decided to accept the recommendations of the Expert Committee and accordingly, vaccines of M/s Serum and M/s Bharat Biotech are being approved for restricted use in emergency situation, DCGI Dr VG Somani said.
India COVID Vaccine: India has logged over 1.3 crore cases of coronavirus so far.
New Delhi: India has moved a step closer to getting a coronavirus vaccine as two candidates - Hyderabad-based Bharat Biotech s Covaxin and the Serum Institute of India s Covishield - have been recommended by a government-appointed panel to the Drugs Controller General of India (DCGI) for emergency use in the last two days. The country has been preparing for the vaccine rollout for the last four months, Health Minister Harsh Vardhan said on Saturday as he reviewed the dry run in Delhi. An end-to-end mock drill on the vaccine administration was conducted in all the states and union territories on Saturday, an exercise compared by the Health Minister to holding elections. DCGI chief Dr Venugopal G Somani is expected to share details about the vaccine candidates today at 11 AM.
Jan 03, 2021, 15:45 IST
NEW DELHI: With India s drugs regulator approving the Oxford COVID-19 vaccine Covishield and Covaxin of Bharat Biotech, Dr Union Minister for Health & Family Welfare, called it a, watershed moment in India’s famed battle against COVID19 under the charismatic leadership of Prime Minister Narendra Modi. The news has led to a mixed response from the Opposition parties.
A watershed moment in India’s famed battle against #COVID19 under the charismatic leadership of Hon’ble PM Sh @narendramodi Ji !
Our wait for #COVID19vaccine is over with COVISHIELD from @SerumInstIndia & COVAXIN from @BharatBiotech approved for emergency use in India@PMOIndiapic.twitter.com/sqjsetqHnU